{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:07:48Z","timestamp":1793678868703,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1844024N"],"award-info":[{"award-number":["1844024N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G038024N"],"award-info":[{"award-number":["G038024N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["C2M\/24\/057"],"award-info":[{"award-number":["C2M\/24\/057"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ajt.2025.03.031","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T02:27:04Z","timestamp":1744079224000},"page":"1410-1416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Microvascular inflammation in kidney allografts: New directions for patient management"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7600-912X","authenticated-orcid":false,"given":"Georg A.","family":"B\u00f6hmig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3388-7747","authenticated-orcid":false,"given":"Alexandre","family":"Loupy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4662-4010","authenticated-orcid":false,"given":"Marta","family":"Sablik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5625-0792","authenticated-orcid":false,"given":"Maarten","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajt.2025.03.031_bib1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2025.03.031_bib2","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1016\/j.ajt.2025.03.031_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/tri.13340","article-title":"A method to reduce variability in scoring antibody-mediated rejection in renal allografts: implications for clinical trials \u2013 a retrospective study","volume":"32","author":"Smith","year":"2019","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.ajt.2025.03.031_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/TP.0000000000005112","article-title":"Banff 2022 kidney commentary: reflections and future directions","volume":"109","author":"Rabant","year":"2025","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2025.03.031_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","article-title":"Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies","volume":"13","author":"de Kort","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.03.031_bib6","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/tri.13964","article-title":"The evolution of histological changes suggestive of antibody-mediated injury, in the presence and absence of donor-specific anti-HLA antibodies","volume":"34","author":"Coemans","year":"2021","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.ajt.2025.03.031_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular inflammation of kidney allografts and clinical outcomes","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajt.2025.03.031_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ajt.15055","article-title":"Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation","volume":"19","author":"Luque","year":"2019","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.03.031_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajt.2024.07.014","article-title":"Probable antibody-mediated rejection in kidney transplantation is a rare and challenging phenotype to define: findings from a single-center study","volume":"25","author":"Wellekens","year":"2025","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2025.03.031_bib10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/TP.0000000000004550","article-title":"On a long and winding road: alloantibodies in organ transplantation","volume":"107","author":"B\u00f6hmig","year":"2023","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.ajt.2025.03.031_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajt.2025.03.031_bib12","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/ajt.13115","article-title":"The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors","volume":"15","author":"Venner","year":"2015","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.03.031_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.kint.2018.08.027","article-title":"Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation","volume":"95","author":"Yazdani","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ajt.2025.03.031_bib14","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/s41467-023-39859-7","article-title":"Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection","volume":"14","author":"Lamarth\u00e9e","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajt.2025.03.031_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.13209","article-title":"Natural killer cell presence in antibody-mediated rejection","volume":"37","author":"Diebold","year":"2024","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.ajt.2025.03.031_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.kint.2021.11.029","article-title":"Allorecognition and the spectrum of kidney transplant rejection","volume":"101","author":"Callemeyn","year":"2022","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.ajt.2025.03.031_bib17","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.17092","article-title":"Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: differences in timing and intensity but similar mechanisms and outcomes","volume":"22","author":"Halloran","year":"2022","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.03.031_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajt.2024.07.023","article-title":"The relationship of microvascular inflammation with antibody-mediated rejection in kidney transplantation","volume":"25","author":"Nankivell","year":"2025","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2025.03.031_bib19","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1111\/ajt.15938","article-title":"Clinical importance of extended second field high-resolution HLA genotyping for kidney transplantation","volume":"20","author":"Senev","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.03.031_bib20","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajt.2025.03.031_bib21","article-title":"Functional natural killer-cell genetics and microvascular inflammation after kidney transplantation: an observational cohort study","author":"Diebold","year":"2024","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ajt.2025.03.031_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ajt.2022.12.018","article-title":"Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: an orphan category in Banff classification with cytotoxic T and natural killer cell infiltration","volume":"23","author":"Buxeda","year":"2023","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.03.031_bib23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.kint.2023.11.026","article-title":"Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass","volume":"105","author":"Cristoferi","year":"2024","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.ajt.2025.03.031_bib24","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1681\/ASN.2020111558","article-title":"Missing self-induced microvascular rejection of kidney allografts: a population-based study","volume":"32","author":"Callemeyn","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ajt.2025.03.031_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajt.2025.03.031_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of felzartamab anti-CD38 treatment on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies","author":"Diebold","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ajt.2025.03.031_bib27","article-title":"Influence of persistent inflammation in follow-up biopsies after antibody-mediated rejection in kidney transplantation","volume":"8","author":"Pi\u00f1eiro","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajt.2025.03.031_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11951","article-title":"Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes","volume":"36","author":"Klein","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.ajt.2025.03.031_bib29","article-title":"Estimating the efficacy of felzartamab to treat antibody-mediated rejection using the iBox prognostication system","author":"Lombardi","year":"2024","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.03.031_bib30","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:28:42Z","timestamp":1762554522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1600613525001704"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.03.031","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microvascular inflammation in kidney allografts: New directions for patient management","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}